BRG1 expression is increased in human cutaneous melanoma

Area of Science:

• Oncology
• Cell Biology
• Chromatin Remodeling

Background:

• The SWI/SNF chromatin remodelling complex is crucial for cellular processes and its aberrant expression is linked to cancer.
• While SNF5 is a known tumor suppressor, the role of the catalytic subunit BRG1 in cancer remains unclear.

Purpose of the Study:

• To investigate the role of BRG1 in melanoma development.
• To analyze BRG1 expression in melanocytic lesions and its correlation with clinicopathological variables and patient survival.

Main Methods:

• Tissue microarray and immunohistochemistry were used to evaluate BRG1 expression in dysplastic naevi, primary melanomas, and metastatic melanomas.
• Small interfering RNA was employed to reduce BRG1 expression in melanoma cell lines, followed by cell proliferation and cell cycle assays.

Main Results:

• BRG1 expression was significantly elevated in primary and metastatic melanomas compared to dysplastic naevi.
• BRG1 knockdown in melanoma cells led to reduced proliferation due to G1 phase arrest, with downregulation of cyclin D1.
• No significant correlation was found between BRG1 expression and melanoma patient survival.

Conclusions:

• BRG1 is significantly upregulated in human melanoma.
• Increased BRG1 expression is implicated in melanoma initiation and progression.
• BRG1 plays a role in regulating melanoma cell proliferation.